Trial record 1 of 1 for:    MM08-141
Previous Study | Return to List | Next Study

Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Hoosier Cancer Research Network
Cephalon
Information provided by (Responsible Party):
Sherif Farag, MB, BS, Hoosier Cancer Research Network
ClinicalTrials.gov Identifier:
NCT01177683
First received: August 5, 2010
Last updated: August 22, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)